Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Revenues $ 2,937,325 $ 1,621,057 $ 5,020,275 $ 2,771,776
Cost of revenues, including depreciation 913,357 469,294 1,802,226 940,361
Gross profit 2,023,968 1,151,763 3,218,049 1,831,415
Operating expenses:        
Personnel 284,886 136,824 469,557 304,686
Marketing and promotion 77,943 45,265 129,704 114,734
General and administrative 814,914 368,557 1,521,397 582,326
Total operating expenses 1,177,743 550,646 2,120,658 1,001,746
Operating income 846,225 601,117 1,097,391 829,669
Non-operating expenses:        
Interest expense, net 267,186 96,312 563,613 177,905
Equity compensation 6,290,802 6,863,609 19,295
Loss on debt settlements 563,119 1,776,960 18,278
Other 3,600 3,600
Total non-operating expenses 7,124,707 96,312 9,207,782 215,478
Net income (loss) (6,278,482) 504,805 (8,110,391) 614,191
Net income (loss) to noncontrolling interests 69,287 (42,195) 132,520 99,431
Net income (loss) attributable to MariMed Inc. $ (6,347,769) $ 547,000 $ (8,242,911) $ 514,760
Net income (loss) per share $ (0.034) $ 0.008 $ (0.045) $ 0.008
Weighted average common shares outstanding 186,645,833 65,593,751 182,746,858 64,912,354